ST 198
Product Specifications
UNSPSC Description
ST 198 is an orally active D3R antagonist. ST 198 can block the expression of nicotine-induced CPP at doses selective for D3R. ST 198 can be used for the research of neurological disease[1].
Target Antigen
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/st-198.html
Solubility
10 mM in DMSO
Smiles
O=C(NCCCCN1CC2=C(C=CC=C2)CC1)/C=C/C3=CC=CC=C3
Molecular Weight
334.45
References & Citations
[1]Le Foll B, et al. Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology. 2005;30(4):720-730.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111280/ST-198-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111280/
Clinical Information
No Development Reported
CAS Number
854924-64-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
